Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2025-12-25 @ 12:53 AM
NCT ID: NCT01909167
Eligibility Criteria: Inclusion Criteria: * To be pregnant * Less than 20 weeks gestation, * To have symptoms of depression (EPDS between 12-22), * To be computer literate, * To have an online computer at home, * English speaking and writing, * Not being in psychiatric or psychological treatment, * Not having a twin pregnancy, * Not having undertaken an IVF (In vitro fertilization) procedure, * Not having the psychiatric problems (based on the patient's notes): psychosis, addiction, history of bipolar disorder, suicidality and other psychiatric diagnoses that do not fall into the affective disorders and/or anxiety disorders spectrum. Exclusion Criteria: * Not pregnant * Having severe symptoms of depression (EPDS above 22), * Computer illiteracy, * No access to the internet, * Not speaking or reading English, * Already being in psychiatric or psychological treatment, * Twin pregnancy, * Having a medical disorder of pregnancy (including abnormal foetus), * Having undertaken an IVF (In vitro fertilization) procedure, * Psychiatric factors based on patient's notes: psychosis, addiction, history of bipolar disorder, suicidality and other psychiatric diagnoses that do not fall into the affective disorders and/or anxiety disorders spectrum. * After birth for baby data: baby born below 35 weeks, baby with any severe disorders. Mothers will continue to be treated if they want to.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 40 Years
Study: NCT01909167
Study Brief:
Protocol Section: NCT01909167